Overview

Bioequivalence Study of Esomeprazole 20 Milligram (mg) Delayed-Release Capsules in Healthy Adult Participants

Status:
Not yet recruiting

Trial end date:
2022-04-30

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate bioequivalence parameters of esomeprazole capsules 20 mg (test product) vs. esomeprazole capsules 20 mg (reference product) under fasted conditions.

Phase:

Phase 1

Details

Lead Sponsor:

GlaxoSmithKline

Treatments:

Esomeprazole